MarketInOut Stock Screener Log In | Sign Up

Sunshine Biopharma Inc Wt

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/19/2026
Sunshine Biopharma Inc Wt stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization0.6623 mln
Float2.90 mln
Earnings Date11/13/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.51
Likely reliable

Relative Strength

14 / 100
Significantly lagging

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-16%
Loss-making

ROE

-23.91
Deeply negative

Business Description

Sunshine Biopharma is a Fort Lauderdale-based company that develops new treatments for serious illnesses such as cancer and viral infections, while also selling a broad range of generic prescription drugs covering conditions from diabetes to heart disease. The company has several medicines in development, including treatments for pancreatic cancer, liver cancer, and coronavirus infections. It also sells over-the-counter health products such as amino acid supplements, calcium, and vitamin D.

Key Fundamentals

EPS-2.21
ROE-23.91
RPS49.67
ROIC-33.29
ROA-18.80
EBITDA, mln-4.85
EV / EBITDA2.42
Revenue, mln35.35

Quote Details

Last 0.025
Change -0.0001 (-0.4%)
Open 0.025
Volume 600
Turnover 15
Average Volume 4,796.43

Financial Ratios

Pre-Tax Profit Margin-16
Leverage Ratio1.22
Current Ratio5.46
Price / Book0.00
Debt / Equity0.03
Price / Sales0.01

Financial Strength

Altman Z-Score-1.54
Piotroski F-Score 4 / 9
Beneish M-Score-2.51

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -35.9% 2 / 100   
1 Month -54.87% 2 / 100   
2 Months -83.32% 1 / 100   
6 Months -92.19% 2 / 100   
1 Year -89.58% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog